Yoshikawa et al., 2000 - Google Patents
Inhaled nitric oxide ameliorates postoperative acute graft dysfunction after living-donor lobar lung transplantationYoshikawa et al., 2000
- Document ID
- 257476932670862778
- Author
- Yoshikawa T
- Date H
- Yamashita M
- Nagahiro I
- Aoe M
- Shimizu N
- Publication year
- Publication venue
- The Japanese Journal of Thoracic and Cardiovascular Surgery
External Links
Snippet
Inhaled nitric oxide, a selective pulmonary vasodilator, decreases mean pulmonary artery pressure and pulmonary vascular resistance and improves oxygenation in previously unobtainable ways without significant changes in systemic hemodynamics. We report …
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitric oxide data:image/svg+xml;base64,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 data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nODVweCcgaGVpZ2h0PSc4NXB4JyB2aWV3Qm94PScwIDAgODUgODUnPgo8IS0tIEVORCBPRiBIRUFERVIgLS0+CjxyZWN0IHN0eWxlPSdvcGFjaXR5OjEuMDtmaWxsOiNGRkZGRkY7c3Ryb2tlOm5vbmUnIHdpZHRoPSc4NS4wJyBoZWlnaHQ9Jzg1LjAnIHg9JzAuMCcgeT0nMC4wJz4gPC9yZWN0Pgo8cGF0aCBjbGFzcz0nYm9uZC0wIGF0b20tMCBhdG9tLTEnIGQ9J00gNjQuNywzNi4yIEwgNDQuMSwzNi4yJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojRTg0MjM1O3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0wIGF0b20tMCBhdG9tLTEnIGQ9J00gNDQuMSwzNi4yIEwgMjMuNCwzNi4yJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojNDI4NEY0O3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0wIGF0b20tMCBhdG9tLTEnIGQ9J00gNjQuNyw0Ny44IEwgNDQuMSw0Ny44JyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojRTg0MjM1O3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0wIGF0b20tMCBhdG9tLTEnIGQ9J00gNDQuMSw0Ny44IEwgMjMuNCw0Ny44JyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojNDI4NEY0O3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8dGV4dCB4PSc2Ni4yJyB5PSc1My42JyBjbGFzcz0nYXRvbS0wJyBzdHlsZT0nZm9udC1zaXplOjIzcHg7Zm9udC1zdHlsZTpub3JtYWw7Zm9udC13ZWlnaHQ6bm9ybWFsO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTpub25lO2ZvbnQtZmFtaWx5OnNhbnMtc2VyaWY7dGV4dC1hbmNob3I6c3RhcnQ7ZmlsbDojRTg0MjM1JyA+TzwvdGV4dD4KPHRleHQgeD0nOC4yJyB5PSc1My42JyBjbGFzcz0nYXRvbS0xJyBzdHlsZT0nZm9udC1zaXplOjIzcHg7Zm9udC1zdHlsZTpub3JtYWw7Zm9udC13ZWlnaHQ6bm9ybWFsO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTpub25lO2ZvbnQtZmFtaWx5OnNhbnMtc2VyaWY7dGV4dC1hbmNob3I6c3RhcnQ7ZmlsbDojNDI4NEY0JyA+TjwvdGV4dD4KPHBhdGggZD0nTSA1LjksNDIuMCBMIDUuOSw0MS45IEwgNS45LDQxLjggTCA1LjksNDEuNyBMIDUuOSw0MS42IEwgNS44LDQxLjUgTCA1LjgsNDEuNCBMIDUuNyw0MS4zIEwgNS43LDQxLjMgTCA1LjYsNDEuMiBMIDUuNSw0MS4xIEwgNS40LDQxLjEgTCA1LjQsNDEuMCBMIDUuMyw0MS4wIEwgNS4yLDQwLjkgTCA1LjEsNDAuOSBMIDUuMCw0MC45IEwgNC45LDQwLjggTCA0LjgsNDAuOCBMIDQuNyw0MC44IEwgNC42LDQwLjkgTCA0LjUsNDAuOSBMIDQuNCw0MC45IEwgNC4zLDQwLjkgTCA0LjIsNDEuMCBMIDQuMSw0MS4wIEwgNC4wLDQxLjEgTCA0LjAsNDEuMiBMIDMuOSw0MS4yIEwgMy44LDQxLjMgTCAzLjgsNDEuNCBMIDMuNyw0MS41IEwgMy43LDQxLjYgTCAzLjcsNDEuNyBMIDMuNiw0MS44IEwgMy42LDQxLjkgTCAzLjYsNDIuMCBMIDMuNiw0Mi4wIEwgMy42LDQyLjEgTCAzLjYsNDIuMiBMIDMuNyw0Mi4zIEwgMy43LDQyLjQgTCAzLjcsNDIuNSBMIDMuOCw0Mi42IEwgMy44LDQyLjcgTCAzLjksNDIuOCBMIDQuMCw0Mi44IEwgNC4wLDQyLjkgTCA0LjEsNDMuMCBMIDQuMiw0My4wIEwgNC4zLDQzLjEgTCA0LjQsNDMuMSBMIDQuNSw0My4xIEwgNC42LDQzLjEgTCA0LjcsNDMuMiBMIDQuOCw0My4yIEwgNC45LDQzLjIgTCA1LjAsNDMuMSBMIDUuMSw0My4xIEwgNS4yLDQzLjEgTCA1LjMsNDMuMCBMIDUuNCw0My4wIEwgNS40LDQyLjkgTCA1LjUsNDIuOSBMIDUuNiw0Mi44IEwgNS43LDQyLjcgTCA1LjcsNDIuNyBMIDUuOCw0Mi42IEwgNS44LDQyLjUgTCA1LjksNDIuNCBMIDUuOSw0Mi4zIEwgNS45LDQyLjIgTCA1LjksNDIuMSBMIDUuOSw0Mi4wIEwgNC44LDQyLjAgWicgc3R5bGU9J2ZpbGw6IzAwMDAwMDtmaWxsLXJ1bGU6ZXZlbm9kZDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6IzAwMDAwMDtzdHJva2Utd2lkdGg6MC4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MTsnIC8+Cjwvc3ZnPgo= O=[N] 0 title abstract description 26
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris with membranes
- A61M1/1698—Blood oxygenators with or without heat-exchangers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/43—Composition of exhalation
- A61M2230/435—Composition of exhalation partial O2 pressure (P-O2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8887721B2 (en) | Attenuation of vasoactive oxygen carrier-induced vasoconstriction | |
CN100488497C (en) | Use of leukotriene in preparing medicament | |
Richter et al. | Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting | |
Zwischenberger et al. | Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure | |
Bredenberg et al. | Respiratory failure in shock | |
Curran et al. | Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension | |
Brunston Jr et al. | Total arteriovenous CO2 removal: simplifying extracorporeal support for respiratory failure | |
McIntyre Jr et al. | Cardiopulmonary effects of permissive hypercapnia in the management of adult respiratory distress syndrome | |
Blomqvist et al. | Enhanced pneumonia resolution by inhalation of nitric oxide? | |
Defouilloy et al. | Polycythemia impairs vasodilator response to acetylcholine in patients with chronic hypoxemic lung disease | |
Yoshikawa et al. | Inhaled nitric oxide ameliorates postoperative acute graft dysfunction after living-donor lobar lung transplantation | |
Mitrouska et al. | Oxygen therapy in chronic obstructive pulmonary disease | |
Nahum et al. | Adjuncts to mechanical ventilation | |
Feeley et al. | The effect of hypothermic preservation of the heart and lungs on cardiorespiratory function following canine heart-lung transplantation | |
Zapol et al. | Inhaled nitric oxide in adult respiratory distress syndrome and other lung diseases | |
Barzaghi et al. | ECMO and inhaled nitric oxide for cardiopulmonary failure after heart retransplantation | |
Maevsky et al. | Perftoran® | |
Ichinose et al. | Inhaled nitric oxide—current practice and future potential uses and development | |
Riddez et al. | Short-term crystalloid fluid resuscitation in uncontrolled intra-abdominal bleeding in swine | |
Gutierrez et al. | Comparison of canine cardiovascular response to inhaled and intraperitoneally infused CO | |
Ueda et al. | Effects of inhaled nitric oxide in a canine living-donor lobar lung transplant model | |
Van Hook | Acute respiratory distress syndrome in pregnancy | |
Weinstein et al. | Management of severe respiratory failure | |
KR20240100777A (en) | Food manufacturing method that enhances blood absorption of inspired oxygen | |
Pappert et al. | Treatment of ARDS with nitric oxide and ECMO |